Life Sciences Law & Industry Report connects the dots among the many disciplines that make up the burgeoning life sciences industry, with biweekly updates on current regulatory, legislative,...
The bill (S. 2713) wouldn't impose any additional requirements on top of provisions already in the White House initiative, announced in January 2015 to advance an emerging model of health-care delivery that targets treatments to patient subgroups identified by their genetic makeup . Instead, the bill would encourage the Department of Health and Human Services to establish and carry out the Precision Medicine Initiative “to augment efforts to address disease prevention, diagnosis, and treatment.”
Introduction of the bill by Sen. Lamar Alexander (R-Tenn.), chairman of the Senate Health, Education, Labor and Pensions Committee, comes about three weeks before his committee is scheduled to hold the third and final markup of legislation in a bipartisan effort to accelerate the development of new drugs and devices. Alexander's office hasn't confirmed that the bill will be on the April 6 markup docket, but the chairman's past remarks indicates it's a likely move for the Senate committee.
The Senate's medical innovation agenda is the companion effort to the House-passed 21st Century Cures bill (H.R. 6), which includes language about precision medicine.
Officially, the HELP committee has only confirmed one bill for the April 6 markup as of March 18. But in announcing that bill on the scientific workforce (S. 2700), the committee said it plans to add more legislation to the docket . Alexander also said when announcing the first of the three markups in February that the medical innovation agenda would include bipartisan legislation in support of precision medicine, but no such bill had come before the committee until S. 2713 was introduced .
Alexander's bill includes requirements the HHS already has started to address to:
The bill also includes language on congressional support for developing new approaches to address scientific, medical, public health and regulatory science issues.
To contact the reporter on this story: Jeannie Baumann in Washington at email@example.com
To contact the editor responsible for this story: Randy Kubetin at firstname.lastname@example.org
The text of S. 2713 is available at http://src.bna.com/dqr.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)